Grant from Smith & Nephew Helps Continue Educational Activities for Podiatric
LONDON, Oct. 30, 2013
LONDON, Oct. 30, 2013 /PRNewswire/ -- Smith & Nephew (NYSE:SNN;LSE:SN), the
global medical technology business, today announced its new educational
relationship with the recently formed American Academy of Foot and Ankle
Osteosynthesis (AAFAO). Through this relationship, a grant from Smith & Nephew
will be used to fund AAFAO's continuing education courses for internal
fixation of the foot and ankle.
(Logo - http://photos.prnewswire.com/prnh/20131030/CL06769LOGO )
"For more than 150 years, we have supported healthcare professionals with
innovative technologies, life-changing treatments and ongoing medical
education," says Mark Waugh, Vice President for Smith & Nephew's Global
Extremities & Limb Restoration Strategic Business Unit. "We are extremely
proud to be working with an organization like AAFAO which shares our
commitment to surgeon education."
In addition to the grant, Smith and Nephew will also provide a new location
for the training courses in its new Innovation Centre. Located in Memphis, TN,
the Centre is a world-class medical training facility dedicated to the
advancement of surgical technology and expertise. Within the two-story,
62,000-square-foot Centre is a 140-seat auditorium, five integrated conference
rooms and 15 lab stations – each with full cadaveric capability, OR lighting
and state-of-the-art operating tables.
The first AAFAO course being offered at the new facility will be
"Comprehensive Course of Internal Fixation for Reconstructive Surgery and
Trauma of the Foot & Ankle." Information and registration for this course is
available on the AAFAO website – www.aafao.org.
The American Academy of Foot and Ankle Osteosynthesis is a new educational
organization dedicated to the training of podiatric residents in the
techniques and skills of skeletal fixation, trauma and reconstructive surgery
of the foot and ankle.
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping
improve people's lives. With leadership positions in Orthopaedic
Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith &
Nephew has around 11,000 employees and a presence in more than 90 countries.
Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member
of the FTSE100 (LSE: SN, NYSE: SNN).
This document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and
trading margins, market trends and our product pipeline are forward-looking
statements. Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target", "consider" and
similar expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual results to
differ materially from what is expressed or implied by the statements. For
Smith & Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care providers, payors
and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement
decisions or other government actions; product defects or recalls; litigation
relating to patent or other claims; legal compliance risks and related
investigative, remedial or enforcement actions; strategic actions, including
acquisitions and dispositions, our success in integrating acquired businesses,
and disruption that may result from changes we make in our business plans or
organisation to adapt to market developments; and numerous other matters that
affect us or our markets, including those of a political, economic, business,
competitive or reputational nature. Please refer to the documents that Smith &
Nephew has filed with the U.S. Securities and Exchange Commission under the
U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's
most recent annual report on Form 20-F, for a discussion of certain of these
Any forward-looking statement is based on information available to Smith &
Nephew as of the date of the statement. All written or oral forward-looking
statements attributable to Smith & Nephew are qualified by this caution. Smith
& Nephew does not undertake any obligation to update or revise any
forward-looking statement to reflect any change in circumstances or in Smith &
^™ Trademark of Smith & Nephew. Certain marks registered US Patent and
Trademark Office. All Trademarks acknowledged.
SOURCE Smith & Nephew
Contact: Media, Joe Metzger, Smith & Nephew, +1 (978) 749-1330, or
Investor/Analyst, Phil Cowdy, Smith & Nephew, +44 (0)20 7401 7646
Press spacebar to pause and continue. Press esc to stop.